Postmastectomy radiotherapy: an American society of clinical oncology, American society for radiation oncology, and society of surgical oncology focused guideline …

A Recht, EA Comen, RE Fine, GF Fleming… - Journal of Clinical …, 2016 - ascopubs.org
Purpose A joint American Society of Clinical Oncology, American Society for Radiation
Oncology, and Society of Surgical Oncology panel convened to develop a focused update of …

Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data

TM Zagar, JR Oleson, Z Vujaskovic… - International Journal …, 2010 - Taylor & Francis
Hyperthermia has long been used in combination with radiation for the treatment of
superficial malignancies, in part due to its radiosensitising capabilities. Patients who suffer …

Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer

BL Fowble, JP Einck, DN Kim, S McCloskey… - International Journal of …, 2012 - Elsevier
PURPOSE: To identify a cohort of women treated with neoadjuvant chemotherapy and
mastectomy for whom postmastectomy radiation therapy (PMRT) may be omitted according …

Postmastectomy radiation therapy in women with T1-T2 tumors and 1 to 3 positive lymph nodes: analysis of the breast international group 02-98 trial

YH Zeidan, JG Habib, L Ameye, M Paesmans… - International Journal of …, 2018 - Elsevier
Purpose To analyze the impact of postmastectomy radiation therapy (PMRT) for patients with
T1-T2 tumors and 1 to 3 positive lymph nodes enrolled on the Breast International Group …

Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy

R Sharma, I Bedrosian, A Lucci, RF Hwang… - Annals of surgical …, 2010 - Springer
Background We sought to determine present-day locoregional recurrence (LRR) rates to
better understand the role of postmastectomy radiotherapy (PMRT) in women with 0 to 3 …

Most breast cancer patients with T1-2 tumors and one to three positive lymph nodes do not need postmastectomy radiotherapy

S Muhsen, TA Moo, S Patil, M Stempel… - Annals of surgical …, 2018 - Springer
Abstract Background/Objective Guidelines concur that postmastectomy radiation therapy
(PMRT) in T1-2 tumors with one to three positive (+) lymph nodes (LNs) decreases …

A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer

SMC Sittenfeld, EC Zabor, SN Hamilton, HM Kuerer… - Cancer, 2022 - Wiley Online Library
Background Post‐mastectomy radiation therapy (PMRT) in women with pathologic stage T1‐
2N1M0 breast cancer is controversial. Methods Data from five North American institutions …

[HTML][HTML] Early-stage young breast cancer patients: impact of local treatment on survival

EJ Bantema-Joppe, L de Munck, O Visser… - International Journal of …, 2011 - Elsevier
PURPOSE: In young women, breast-conserving therapy (BCT), ie, lumpectomy followed by
radiotherapy, has been associated with an increased risk of local recurrence. Still, there is …

Post-mastectomy radiotherapy for breast cancer patients with T1-T2 and 1-3 positive lymph nodes: a meta-analysis

Y Li, MS Moran, Q Huo, Q Yang, BG Haffty - PLoS One, 2013 - journals.plos.org
Background The role of post-mastectomy radiotherapy (PMRT) in patients with T1-2 and 1-3
positive lymph nodes remains controversial. The aim of this study is to investigate the …

[HTML][HTML] Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

P Karlsson, BF Cole, BH Chua, KN Price, J Lindtner… - Annals of oncology, 2012 - Elsevier
Background Rates and risk factors of local, axillary and supraclavicular recurrences can
guide patient selection and target for postmastectomy radiotherapy (PMRT). Patients and …